Diagnostics firm behind rapid lateral flow test receives £2m investment

A UK firm behind a rapid COVID-19 test that can identify infectious patients has secured £2 million of committed investment for 2021. Iceni Diagnostics expects results from trials of its rapid lateral flow test for COVID-19 imminently.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: